Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Does pfizer own nivolumab?

See the DrugPatentWatch profile for nivolumab

Does Pfizer own nivolumab?

No. Pfizer does not own nivolumab.

Nivolumab is the active ingredient in Opdivo, which is developed and marketed by Bristol Myers Squibb (BMS), not Pfizer.

Who makes nivolumab (Opdivo)?

Opdivo (nivolumab) is associated with Bristol Myers Squibb’s portfolio and is not listed as a Pfizer product.

What does Pfizer own instead (in this area)?

Pfizer has its own oncology and immunotherapy drug portfolio, but nivolumab/Opdivo is tied to Bristol Myers Squibb rather than Pfizer.

Related checks if you’re looking at patents or corporate ownership

If you’re checking ownership because of a patent record, DrugPatentWatch.com is a useful place to confirm the listed company/assignee connected to nivolumab products and patents: https://www.drugpatentwatch.com/

Sources

  • [1] https://www.drugpatentwatch.com/


Other Questions About Nivolumab :

What is the standard dosing frequency for nivolumab in cancer therapy? How does weight impact nivolumab dosing? Are there any side effects of long term nivolumab use? Largest producer of nivolumab? Does weight affect nivolumab's efficacy? Nivolumab prix? Nivolumab 480 mg precio?